Autoimmunity against the second extracellular loop of β1-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo

Michikado Iwata, Tsutomu Yoshikawa, Akiyasu Baba, Toshihisa Anzai, Iwao Nakamura, Yumiko Wainai, Toshiyuki Takahashi, Satoshi Ogawa

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Although immunoapheresis removing autoantibodies against the second extracellular domain of β1-adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of β1-AR once a month with (β + biso rabbits, n= 10) or without (β rabbits, n = 13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (n = 13). Autoantibodies of IgG isotype against the domain were persistently detected in β and β + biso rabbits. Purified IgG from sera of β and β + biso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, β-AR uncoupling with increased G protein - coupled receptor kinase 5 (GRKS) expression was found in β rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in β rabbits. This was accompanied by decreased β1-AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in β rabbits at 6 months were prevented in β + biso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of β1-ARs induced profound β-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes.

Original languageEnglish
Pages (from-to)578-586
Number of pages9
JournalCirculation Research
Volume88
Issue number6
Publication statusPublished - 2001 Mar 30

Fingerprint

Autoimmunity
Adrenergic Receptors
Hypertrophy
Rabbits
Bisoprolol
Autoantibodies
G-Protein-Coupled Receptor Kinase 5
Immunoglobulin G
Sympathomimetics
Membranes
Left Ventricular Hypertrophy
Cardiomyopathies
GTP-Binding Proteins
Norepinephrine
Hemodynamics
Observation
Peptides

Keywords

  • β-adrenergic receptor
  • Autoimmunity
  • Cardiac dysfunction
  • Cardiomyopathy
  • Hypertrophy

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Autoimmunity against the second extracellular loop of β1-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo. / Iwata, Michikado; Yoshikawa, Tsutomu; Baba, Akiyasu; Anzai, Toshihisa; Nakamura, Iwao; Wainai, Yumiko; Takahashi, Toshiyuki; Ogawa, Satoshi.

In: Circulation Research, Vol. 88, No. 6, 30.03.2001, p. 578-586.

Research output: Contribution to journalArticle

Iwata, Michikado ; Yoshikawa, Tsutomu ; Baba, Akiyasu ; Anzai, Toshihisa ; Nakamura, Iwao ; Wainai, Yumiko ; Takahashi, Toshiyuki ; Ogawa, Satoshi. / Autoimmunity against the second extracellular loop of β1-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo. In: Circulation Research. 2001 ; Vol. 88, No. 6. pp. 578-586.
@article{a89c7fa2993744248434fa83994ba74c,
title = "Autoimmunity against the second extracellular loop of β1-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo",
abstract = "Although immunoapheresis removing autoantibodies against the second extracellular domain of β1-adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of β1-AR once a month with (β + biso rabbits, n= 10) or without (β rabbits, n = 13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (n = 13). Autoantibodies of IgG isotype against the domain were persistently detected in β and β + biso rabbits. Purified IgG from sera of β and β + biso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, β-AR uncoupling with increased G protein - coupled receptor kinase 5 (GRKS) expression was found in β rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in β rabbits. This was accompanied by decreased β1-AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in β rabbits at 6 months were prevented in β + biso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of β1-ARs induced profound β-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes.",
keywords = "β-adrenergic receptor, Autoimmunity, Cardiac dysfunction, Cardiomyopathy, Hypertrophy",
author = "Michikado Iwata and Tsutomu Yoshikawa and Akiyasu Baba and Toshihisa Anzai and Iwao Nakamura and Yumiko Wainai and Toshiyuki Takahashi and Satoshi Ogawa",
year = "2001",
month = "3",
day = "30",
language = "English",
volume = "88",
pages = "578--586",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Autoimmunity against the second extracellular loop of β1-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo

AU - Iwata, Michikado

AU - Yoshikawa, Tsutomu

AU - Baba, Akiyasu

AU - Anzai, Toshihisa

AU - Nakamura, Iwao

AU - Wainai, Yumiko

AU - Takahashi, Toshiyuki

AU - Ogawa, Satoshi

PY - 2001/3/30

Y1 - 2001/3/30

N2 - Although immunoapheresis removing autoantibodies against the second extracellular domain of β1-adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of β1-AR once a month with (β + biso rabbits, n= 10) or without (β rabbits, n = 13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (n = 13). Autoantibodies of IgG isotype against the domain were persistently detected in β and β + biso rabbits. Purified IgG from sera of β and β + biso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, β-AR uncoupling with increased G protein - coupled receptor kinase 5 (GRKS) expression was found in β rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in β rabbits. This was accompanied by decreased β1-AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in β rabbits at 6 months were prevented in β + biso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of β1-ARs induced profound β-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes.

AB - Although immunoapheresis removing autoantibodies against the second extracellular domain of β1-adrenergic receptors (ARs) improves cardiac function in patients with cardiomyopathy, the underlying mechanisms have not been defined. We examined the role of autoimmunity against the domain in the development of cardiac dysfunction in vivo. Japanese white rabbits were immunized with a synthetic peptide corresponding to the second extracellular loop of β1-AR once a month with (β + biso rabbits, n= 10) or without (β rabbits, n = 13) bisoprolol treatment (2 mg/kg per day). Control rabbits received vehicle without bisoprolol treatment (n = 13). Autoantibodies of IgG isotype against the domain were persistently detected in β and β + biso rabbits. Purified IgG from sera of β and β + biso rabbits increased cAMP production in a rabbit cardiac membrane preparation, which was blocked by bisoprolol. At 3 months, β-AR uncoupling with increased G protein - coupled receptor kinase 5 (GRKS) expression was found in β rabbits. At 6 months, left ventricular hypertrophy was noted with hemodynamic derangements in β rabbits. This was accompanied by decreased β1-AR density and increased inhibitory G protein and GRK5 expression, which were related to marked decrease in membrane cAMP production. These changes in β rabbits at 6 months were prevented in β + biso rabbits. There was no difference in the plasma norepinephrine concentration in the 3 groups over the observation period. Thus, autoimmunity against the second extracellular loop of β1-ARs induced profound β-AR desensitization and myocardial hypertrophy in vivo, associated with cardiac dysfunction. Sustained sympathomimetic-like actions of autoantibodies against the domain may be partly responsible for these changes.

KW - β-adrenergic receptor

KW - Autoimmunity

KW - Cardiac dysfunction

KW - Cardiomyopathy

KW - Hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=0035970514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035970514&partnerID=8YFLogxK

M3 - Article

C2 - 11282891

AN - SCOPUS:0035970514

VL - 88

SP - 578

EP - 586

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -